5 active not recruiting, 2 completed, 1 recruiting, 1 suspended. 9 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Active not recruiting 5, Completed 2, Recruiting 1, Suspended 1 |
| Phase 2 | 1 | Suspended 1 |
Follow Radiography: new trials by email Literature Review of Radiography trials Research Report on Radiography
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT) Bone Scan, Carboplatin, Computed Tomography - Stage I Mixed Cell Type Kidney Wilms Tumor, Stage II Mixed Cell Type Kidney Wilms Tumor | Phase 3 | Recruiting | Children's Oncology Group | 1656 | 2025-04-15 | 2026-08-25 |
| A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma Bone Scan, Cabozantinib S-malate, Cisplatin - High Grade Osteosarcoma, Localized Osteosarcoma | Phase 2 / Phase 3 | Suspended | National Cancer Institute (NCI) | 1122 | 2023-03-03 | 2026-10-27 |
| A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma | Phase 3 | Active not recruiting | Children's Oncology Group | 113 | 2021-09-14 | 2026-07-30 |
| Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer Biospecimen Collection, Brachytherapy, Computed Tomography - Endometrial Endometrioid Adenocarcinoma, Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 164 | 2020-04-09 | 2026-07-02 |
| Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors Biospecimen Collection, Cabozantinib S-malate, Computed Tomography - Functioning Pancreatic Neuroendocrine Tumor, Intermediate Grade Lung Neuroendocrine Neoplasm | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 298 | 2018-10-26 | 2026-10-26 |
| Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer Biopsy Procedure, Biospecimen Collection, Colonoscopy - Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 344 | 2018-07-05 | 2026-10-26 |
| Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Blinatumomab - Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 488 | 2014-05-19 | 2026-09-21 |
| Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery 3-Dimensional Conformal Radiation Therapy, Biospecimen Collection, Capecitabine - Pancreatic Adenocarcinoma, Pancreatic Ductal Adenocarcinoma | Phase 3 | Completed | National Cancer Institute (NCI) | 546 | 2010-04-05 | 2026-02-23 |
| Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents Blood sample, Radiography - Growth Hormone Deficiency | Phase 3 | Completed | Pfizer | 90 | 2002-04-01 | 2007-07-30 |
Adenoma, Islet Cell (1) · Anal Canal Carcinoma (1) · Anus Neoplasms (1) · Burkitt Lymphoma (1) · Carcinosarcoma (1) · Dwarfism, Pituitary (1) · Neuroendocrine Tumors (1) · Non functioning pancreatic endocrine tumor (1) · Osteosarcoma (1) · Pancreatic Intraductal Neoplasms (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Rhabdomyosarcoma (1) · Rhabdomyosarcoma, Alveolar (1) · Rhabdomyosarcoma, Embryonal (1)
National Cancer Institute (NCI) (6) · Children's Oncology Group (2) · Pfizer (1)
United States (8) · Canada (6) · Australia (3) · Puerto Rico (3) · Israel (2) · New Zealand (2) · Belgium (1) · Saudi Arabia (1)
Elizabeth A Mullen (1) · Floor Backes (1) · Jennifer A Chan (1) · Lakshmi Rajdev (1) · Mark R Litzow (1) · Michael W Bishop (1) · Ross A Abrams (1) · Wendy Allen-Rhoades (1)
PMID 32589970, PMID 33152282, PMID 33370024, PMID 34340209, PMID 37222189, PMID 37598723, PMID 38131628, PMID 39047240, PMID 39282913, PMID 40966692, PMID 41524552, PMID 42456089, PMID 42832396
U10CA180886 (3), U10CA180820 (2), U10CA180868 (2), U10CA021115 (1), U10CA021661 (1), U10CA180821 (1), U10CA180830 (1), U24CA196172 (1)